Allergan, is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live good life.
Company Growth (employees)
Dublin, IE
Size (employees)
16,700 (est)-46%
Allergan was founded in 1948 and is headquartered in Dublin, IE

Key People at Allergan

Robert Stewart

Robert Stewart

Chief Operating Officer
Brenton Saunders

Brenton Saunders

Chairman of the Board of Directors, Chief Executive Officer and President
William Meury

William Meury

Chief Commercial Officer

Allergan Office Locations

Allergan has offices in Dublin and Parsippany-Troy Hills
Parsippany-Troy Hills, US
400 Interpace Pkwy

Allergan Data and Metrics

Allergan Financial Metrics


Market capitalization (20-Jul-2017)

83.7 b

Closing share price (20-Jul-2017)


Cash (31-Dec-2014)

4.9 b


80.9 b
Allergan's current market capitalization is $83.7 b.
USDFY, 2013FY, 2014


3 b4.9 b

Accounts Receivable

883.3 m914.5 m


285.3 m296 m

Current Assets

5.3 b6.9 b


923.2 m1 b


2.3 b2.4 b

Total Assets

10.6 b12.4 b

Accounts Payable

283.2 m287.4 m

Total Debt

2.2 b2.2 b

Current Liabilities

1.2 b1.6 b

Additional Paid-in Capital

3 b3.4 b

Retained Earnings

4.6 b5.9 b

Total Equity

6.5 b7.8 b

Debt to Equity Ratio

0.3 x0.3 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.6 x1.6 x
USDFY, 2013FY, 2014

Net Income

988.7 m1.5 b

Depreciation and Amortization

254.6 m248.1 m


(27 m)(44 m)

Accounts Payable

37.4 m1.9 m

Cash From Operating Activities

1.7 b1.9 b

Purchases of PP&E

(171.9 m)(243.9 m)

Cash From Investing Activities

(1.4 b)182.7 m

Cash From Financing Activities

28.2 m(204 m)

Income Taxes Paid

455.3 m487.8 m
Y, 2014


42 x


0.3 x


0.2 x

Financial Leverage

1.6 x

Allergan Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
ZELTIQ Aesthetics (CoolSculpting)February 15, 2017$2.5 b

Allergan Market Value History

Allergan Median Salaries

Source: 108 public H-1B filings from Allergan

Traffic Overview of Allergan

Allergan Online and Social Media Presence

Allergan News and Updates

Allergan Buys Regenerative Medicine Unit LifeCell for $2.9 Billion

The pharma company will pay for the deal in cash.

Botox-maker Allergan just picked up a regenerative medicine company for $2.9 billion (AGN)

Allergan is acquiring regenerative medicine company LifeCell for $2.9 billion, the company said Monday.  The purchase is Allergan's first step into regenerative medicine, which it plans to apply to the plastic surgery space.  "The acquisition of LifeCell is both strategicall…

AstraZeneca licences Crohn's disease treatment to Allergan for $1.5bn

Drug giant AstraZeneca has struck a deal with Ireland-based pharma firm Allergan to licence a treatment for Crohn's disease. Allergan will pay $250m upfront and make further payments of up to $1.27bn depending on how the drug performs.  AstraZeneca's shares climbed on the news and were earlier…

Why Allergan Is Willing to Pay So Much Money for This Biotech

It could wind up paying 19 times the firm's share value.

Allergan to buy pharma firm in $639m buyout

Irish pharma firm Allergan is buying psoriasis and autoimmune treatment developer Vitae Pharmaceuticals for $639m (£484m) in cash as it hopes to expand its dermatology division – best known for its Botox treatment. Allergan and US rival Pfizer have been on buying sprees since the US treasury step…

Allergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices

Including a promise for reasonable drug prices.
Show more

Allergan Company Life and Culture

You may also be interested in